On the basis of this large case-control study nested in the ProtecT trial, there was some evidence that increasing alcohol consumption and frequency of drinking were associated with lower PSA and weaker evidence that they were also associated with lower risk of PSA-detected prostate cancer among current drinkers, with generally wide confidence intervals. Here, KLK3 is linked to prostate cancer.